Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 metabolism in calcium-deficient rats
- PMID: 2839142
- PMCID: PMC1148911
- DOI: 10.1042/bj2500671
Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 metabolism in calcium-deficient rats
Abstract
The effect of 24,25-dihydroxyvitamin D3 [24,25(OH)2D3] on 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] metabolism was examined in rats fed on a low-calcium diet. These rats exhibit hypocalcaemia, high urinary cyclic AMP excretion, a markedly elevated serum 1,25(OH)2D concentration and low serum concentrations of both 24,25(OH)2D and 25(OH)D. When the rats are treated orally with 1, 5 or 10 micrograms of 24,25(OH)2D3/100 g every day, there is a dramatic decrease in serum 1,25(OH)2D concentration in a dose-dependent manner concomitant with an increase in serum 24,25(OH)2D concentration. Serum calcium concentration and urinary cyclic AMP excretion are not significantly affected by the 24,25(OH)2D3 treatment, which suggests that parathyroid function is not affected by the 24,25(OH)2D3 treatment. The 25(OH)D3 1 alpha-hydroxylase activity measured in kidney homogenates is markedly elevated in rats on a low-calcium diet but is not affected by any doses of 24,25(OH)2D3. In contrast, recovery of intravenously injected [3H]1,25(OH)2D3 in the serum is decreased in 24,25(OH)2D3-treated rats. Furthermore, when [3H]1,25(OH)2D3 is incubated in vitro with kidney or intestinal homogenates of 24,25(OH)2D3-treated rats there is a decrease in the recovery of radioactivity in the total lipid extract as well as in the 1,25(OH)2D3 fraction along with an increase in the recovery of radioactivity in the water-soluble phase. These results are consistent with the possibility that 24,25(OH)2D3 has an effect on 1,25(OH)2D3 metabolism, namely that of enhancing the degradation of 1,25(OH)2D3. However, because a considerable proportion of the injected 24,25(OH)2D3 is expected to be converted into 1,24,25(OH)3D3 by renal 1 alpha-hydroxylase in 24,25(OH)2D3-treated rats, at least a part of the decrease in serum 1,25(OH)2D concentration may be due to a competitive inhibition by 24,25(OH)2D3 of the synthesis of 1,25(OH)2D3 from 25(OH)D3. Thus the physiological importance of the role of 24,25(OH)2D3 in regulating the serum 1,25(OH)2D concentration as well as the mechanism and metabolic pathway of degradation of 1,25(OH)2D3 remain to be clarified.
Similar articles
-
Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3.Endocrinology. 1989 Jan;124(1):511-7. doi: 10.1210/endo-124-1-511. Endocrinology. 1989. PMID: 2783309
-
Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.Biosci Rep. 1993 Feb;13(1):27-39. doi: 10.1007/BF01138176. Biosci Rep. 1993. PMID: 8392394
-
Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate.J Clin Invest. 1986 Sep;78(3):622-8. doi: 10.1172/JCI112619. J Clin Invest. 1986. PMID: 3489007 Free PMC article.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Metabolism of 1,25-dihydroxyvitamin D3.Physiol Rev. 1984 Apr;64(2):478-504. doi: 10.1152/physrev.1984.64.2.478. Physiol Rev. 1984. PMID: 6324253 Review.
Cited by
-
Association of increased active PTH(1-84) fraction with decreased GFR and serum Ca in predialysis CRF patients: modulation by serum 25-OH-D.Osteoporos Int. 2008 May;19(5):709-16. doi: 10.1007/s00198-007-0554-2. Epub 2008 Feb 1. Osteoporos Int. 2008. PMID: 18239958
-
Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D3 or lactosylceramide treatment to enhance fracture repair.J Orthop Translat. 2020 Apr 27;23:77-88. doi: 10.1016/j.jot.2020.03.013. eCollection 2020 Jul. J Orthop Translat. 2020. PMID: 32518749 Free PMC article.
-
Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat.J Clin Invest. 1990 Oct;86(4):1313-9. doi: 10.1172/JCI114840. J Clin Invest. 1990. PMID: 2212016 Free PMC article.
-
Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells.Calcif Tissue Int. 1993 Mar;52(3):255-60. doi: 10.1007/BF00298729. Calcif Tissue Int. 1993. PMID: 8481842
-
Identification of a vitamin D responsive element in the promoter of the rat cytochrome P450(24) gene.Nucleic Acids Res. 1994 Jun 25;22(12):2410-6. doi: 10.1093/nar/22.12.2410. Nucleic Acids Res. 1994. PMID: 8036172 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources